ad image

Neurocrine Biosciences

1 / 1
Neurocrine Biosciences
Bioscience

Neurocrine Biosciences Presents Breadth of Data Over Time Following Treatment With INGREZZA Capsules

Neurocrine Biosciences

PR-10-24-NI-71Nov 04, 2024
Takeda
Drug Development

Neurocrine Biosciences and Takeda Announce Collaboration to Develop and Commercialize Potential Therapies for Psychiatric Disorders

Takeda

PR-M06-20-NI-019Jun 16, 2020
Neurocrine Biosciences
Drug Development

Neurocrine Biosciences to Present Data on INGREZZA® (valbenazine) and Opicapone at the 2018 World Congress on Parkinson's Disease and Related Disorders

Neurocrine Biosciences

PR-M09-18-NI-058Sep 20, 2018
1 / 1